Ilaria Rancan

Siena, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Enterococcus faecium bacteraemia: a multicentre observational study focused on risk factors for clinical and microbiological outcomes.

Enterococcus faecium bacteraemia: a multicentre observational study focused on risk factors for clinical and microbiological outcomes.

Journal: The Journal of antimicrobial chemotherapy
Published: February 08, 2025

Evolution of Self-reported Neuropsychiatric Symptoms After Switching from Dolutegravir/Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide: Results from the Randomized DOBINeuro Trial.

Evolution of Self-reported Neuropsychiatric Symptoms After Switching from Dolutegravir/Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide: Results from the Randomized DOBINeuro Trial.

Journal: Infectious diseases and therapy
Published: August 31, 2024

Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses.

Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses.

Journal: Cell reports
Published: April 29, 2024

Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant.

Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant.

Journal: Expert review of vaccines
Published: March 22, 2024

Trend over time of HIV-1 drug resistance to nonnucleoside reverse transcriptase inhibitors (NNRTIs) and their drivers: A cohort study from Antiviral Response Cohort Analysis (ARCA).

Trend over time of HIV-1 drug resistance to nonnucleoside reverse transcriptase inhibitors (NNRTIs) and their drivers: A cohort study from Antiviral Response Cohort Analysis (ARCA).

Journal: HIV medicine
Published: February 28, 2023

Safety and Efficacy of Outpatient Treatments for COVID-19: Real-Life Data from a Regionwide Cohort of High-Risk Patients in Tuscany, Italy (the FEDERATE Cohort).

Safety and Efficacy of Outpatient Treatments for COVID-19: Real-Life Data from a Regionwide Cohort of High-Risk Patients in Tuscany, Italy (the FEDERATE Cohort).

Journal: Viruses
Published: December 31, 2022

B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV.

B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV.

Journal: Communications medicine
Published: June 29, 2022

B cell analyses after SARS-CoV-2 mRNA third vaccination reveals a hybrid immunity like antibody response.

B cell analyses after SARS-CoV-2 mRNA third vaccination reveals a hybrid immunity like antibody response.

Journal: Nature communications
Published: May 25, 2022

Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants.

Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants.

Journal: Nature
Published: August 19, 2021

Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine.

Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine.

Journal: Frontiers in immunology
Published: July 13, 2021

Discrepancies between Vaccine Documentation and Serologic Status for Diphtheria, Tetanus, and Hepatitis B in Internationally Adopted Children.

Discrepancies between Vaccine Documentation and Serologic Status for Diphtheria, Tetanus, and Hepatitis B in Internationally Adopted Children.

Journal: Vaccines
Published: July 17, 2020
Showing 1-11 of 11

Last Updated: 09/26/2026